ICON plc is classed by the SEC under Services-Commercial Physical & Biological Research (industry code 8731), based in Dublin 18, IE. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $8.3 billion and a profit of $229 million (its filed statements).
Project businessServices-Commercial Physical & Biological ResearchDublin 18, IEfilings since 20018 of 9 filed, 1 estimated
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a project business: prior from its industry code (SEC 8731, Services-Commercial Physical & Biological Research); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 5.6 out of ten, 8 of 9 metrics filed and 1 estimated: past 6.0 out of ten, present 5.9 out of ten, future 4.4 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 5.4 out of ten. 1 warning event since 2017; the latest 2026-05-01. 54th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 7.6 out of ten. +19.5% a year over 10 filed years; profitable in 10 of 10. 76th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 3.5 out of ten. Share count shrank 1.3% a year. 36% of cash flow returned. Insiders: 37 sales, 0 purchases. 35th percentile among 6 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Financial health (present): 6.1 out of ten. ROE 2%: 2¢ of profit per shareholder dollar. Leverage 43%: owes 43¢ per asset dollar. 61st percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 6.8 out of ten. top 32% of 12 in its family; net margin 2.8%. 68th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 3.8 out of ten. CrossAssetData estimate 3.8/10, confidence 20 of 100 (family median). 50th percentile among 9 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
Room to expand (future): 4.2 out of ten. bottom 42% of 12 in its family for room to expand. 42nd percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 5.7 out of ten. top 43% of 12 in its family for growth drivers. 57th percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 3.5 out of ten. bottom 35% of 11 in its family for expectations against reality. 35th percentile among 11 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 20-F filed 2026-05-27 for the period ended 2025-12-31 (on EDGAR). Newest filing: Form 6-K, 2026-10-08. Filings on record since 2001. Read from EDGAR 2026-10-12.
Where the revenue comes from
By geography: Ireland 39%, United States 31%, Rest of Europe 19%, Rest of World 12%. As tagged in its annual report (Form 20-F, filed 2026-05-27).
Who runs it
Balfe, Barry Edward (Chief Executive Officer); Clerkin, Nigel Bernard John (Chief Financial Officer); Lyons, Emer (Chief Accounting Officer); Climax, John Dr (director); Mccague, Eugene Pacelli (director); Murphy, Ronan Martin (director); Egan, Kevin Francis (director); Grais, Linda (director); Murray, Ciaran (director); O'Neill, Julie (director); and 3 more. 13 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.